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Bromoacetylalprenololmenthane w s found to inhibit hormone-induced fl-adrenergic receptor internaliza- 
tion in a dose-dependent fashion in $49 lymphoma cells, besides its known ability to bind to #-receptors 
irreversibly. This new found property of BAAM + was taken advantage of in studying whether eceptor in- 
ternalization is a necessary step in the desensitization f adenylate cyclase. BAAM-treated cells showed 
functional desensitization even when receptor internalization had been blocked substantially by 50-65%. 
This finding suggests that receptor internalization is not directly involved in desensitization. 
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1. INTRODUCTION 
fl-Adrenergic agonists induce at least two 
distinguishable events at the cellular level: stimula- 
tion of intracellular cAMP accumulation and in- 
ternalization of a proportion of the cell surface 
receptors. The rate of cAMP accumulation rapidly 
declines shortly after stimulation with hormone, 
the system becomes 'desensitized'. Receptor inter- 
nalization has been proposed to play a significant 
part in desensitization [1,2]. However, recent 
evidence suggests that under certain conditions 
receptor internalization is not required for func- 
tional desensitization [3,4]. We show here that the 
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#-antagonist BAAM which has been described to 
bind irreversibly to #-receptors [5], significantly 
modulates the rate of internalization of those 
receptors that remain accessible to hormone. In 
contrast, the observed agonist-induced decline in 
adenylate cyclase activity of intact cells was com- 
pletely unaffected by the irreversible blockade of 
part of the receptors. We conclude therefore that 
receptor internalization is not directly involved in 
the desensitization of the enzyme activity. 
2. MATERIALS AND METHODS 
$49 wild type cells were grown in DMEM con- 
taining 10% fetal calf serum in a growth cabinet 
(95:5 air/CO2, v/v, 37°C) to a density of 1-2 x 
106 cells per ml. 
All reagents used were of standard purity as is 
commercially available. ( - ) - Isoproterenol  bitar- 
trate was obtained from Sigma, and BAAM was a 
gift from Dr J. Pitha, Bethesda, MD, USA. 
To achieve an irreversible blockade of cell sur- 
face receptors, cells were treated with the an- 
tagonist BAAM in the following manner. Cells 
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were incubated with BAAM added from an 
ethanolic stock solution at 4°C for 30 rain, cen- 
trifuged (5 min, 1500 rpm), and washed in the cold 
six times with Hepes-buffered DMEM, pH 7.4 [6], 
containing 0.03070 bovine serum albumin (Fluka) 
followed by one wash with Hepes-buffered 
DMEM. Cells were finally resuspended in a 
calculated volume of ice-cold Dulbecco medium 
and preequilibrated to the temperature at which 
the experiments were performed. Receptor 
numbers were determined by Scatchard analysis of 
saturation binding of [3H]CGP-12177 (between 0.1 
and 1.5 nM) at 30°C as described before [7]. In- 
tracellular cAMP accumulation was measured at 
37°C and was stopped by pipetting 0.5 ml of cell 
suspension into an equal volume of ice-cold 
trichloroacetic acid (10°70). After centrifugation 
the supernatant was extracted 4 times with l ml of 
diethyl ether and the cAMP content in the aqueous 
phase was measured using the [3H]cAMP assay kit 
from Amersham, England. 
3. RESULTS AND DISCUSSION 
Treatment of intact $49 cells with BAAM 
resulted in an irreversible blockade of/5'-receptors. 
This was established by Scatchard analysis of 
radioligand binding using 3H-CGP-12177 which is 
specific for surface receptors [6] and by dose- 
response curves of IPR-dependent cAMP ac- 
cumulation (not shown). The number of blocked 
receptors increased with increasing concentrations 
of BAAM applied. A concentration of 0.5-1.0/~M 
BAAM was required to block 50°7o of the 
receptors. 
$49 cells carrying a reduced number of receptors 
accessible to hormone showed a decrease in the 
rate of hormone-induced receptor internalization 
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Fig. 1. Comparison of the number of cell surface receptors before and after desensitization with 1 x 10 -6 M IPR at 37°C 
in $49 cells carrying varied proportions of receptors blocked with BAAM. (A) Time course of internalization i cells 
pretreated with 0.25/zM (m), 0.63/~M (*), and 2.0/~M (e) BAAM and non-treated control cells (o). Data points at 
time 0 denote receptor numbers before hormone addition. One out of two independent experiments shown. (B) Receptor 
number before (open symbols) and after (full symbols) 10 min desensitization i  cells pretreated with five different 
concentrations of BAAM and non-treated control cells (©,o). Receptor numbers per cell were determined by 
Scatchard analysis of [3H]CGP-12177 saturation binding curves. 
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(fig.l). In fig.1 the results of two types of ex- 
periments are shown. $49 cells were incubated with 
various amounts of BAAM as indicated and the 
numbers of unlabelled cell surface receptors were 
determined from Scatchard plots of saturation 
binding experiments with [3H]CGP-12177. Fig.lA 
shows the time course of receptor internalization 
over 5 min at 1 x 10 -6 M IPR (37°C) for 3 cell bat- 
ches pretreated with different concentrations of 
BAAM and one untreated control. Fig.lB shows 
the degree of internalization as a function of 
BAAM concentration. The extent of receptor in- 
ternalization achieved uring a 10 min incubation 
with 1 x 10 -6 M IPR at 37°C is plotted against he 
BAAM concentrations with which the cells had 
been pretreated beforehand. Both sets of ex- 
periments indicate that after BAAM treatment the 
rate of internalization slows down. The rate of in- 
ternalization was reduced by 50-65°7o after ap- 
plication of 0.63/~M BAAM. Pretreatment with 
concentrations in excess of 2.0/zM BAAM com- 
pletely prevented internalization, i.e. 1 x 10-6M 
IPR produced no change in the number of recep- 
tors still accessible to CGP-12177 binding. 
In contrast, treatment with BAAM did not seem 
to have any effect on desensitization (fig.2). Fig.2 
shows the transient accumulation of intracellular 
cAMP after stimulation of BAAM (0.63/zM) 
pretreated and non-treated $49 cells with 1 x 
10 -6 M IPR at 37°C in the absence of 
phosphodiesterase inhibitor. BAAM-treated cells 
produced less cAMP than non-treated cells which 
is in accordance with the reduction in available 
receptor numbers [8]. The time courses of the rise 
and decline in cAMP content for control and 
pretreated cells run, however, in parallel. This is 
also the case after washing out the hormone and 
reincubation of an aliquot of cells with 1 × 10 -6 M 
IPR (fig.2). In all cases, the maximal cAMP 
response is reached after about 2 rain. The ratio 
between the maximal increases in cAMP before 
and after renewed hormone stimulation is also very 
similar for BAAM-treated cells and control cells. 
Thus receptor blockade with BAAM alters the 
rate of internalization of non-blocked receptors 
but not the biological function of the transducing 
system, i.e. its desensitization. This indicates that 
internalization is not a sequential step in the desen- 
sitization process. 
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Fig.2. Time course of desensitization of adenylate cyclase activity in $49 cells pretreated with 0.63/zM BAAM ( i ,  o) 
and in non-treated $49 cells (o,©). Cells were incubated with 1 × 10-6M IPR at 37°C in DMEM containing no 
phosphodiesterase inhibitor. Aliquots were taken and assayed for cyclase activity (full symbols). At the times indicated 
further aliquots were washed with hormone-free medium and were resuspended in an identical volume of DMEM. The 
cells were then again incubated with 1 × 10 -6 M IPR at the times denoted by the arrow tips and cAMP accumulation 
measured as before (open symbols). One typical experiment out of three performed is shown. 
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Although BAAM has not previously been 
reported to block internalization, it is not unique 
in doing so. Phenylarsine oxide [9], concanavalin 
A [10] or the reduction of the cellular ATP content 
[11] also prevent internalization. So far, only one 
study (with phenylarsine oxide) also shows a func- 
tional aspect of desensitization, i.e. the agonist- 
induced reduction in adenylate cyclase activation, 
to be unrelated to receptor internalization [4]. But 
none of the cited workers reports a dose-related 
modulation of receptor internalization as is seen 
with BAAM. BAAM might therefore prove useful 
in future studies of the mechanism of receptor in- 
ternalization. 
We investigated further whether the BAAM- 
mediated reduction in hormone-accessible recep- 
tors was responsible for the observed inhibition of 
internalization. We chose to approach this ques- 
tion by reducing the number of surface receptors in 
a different manner. We pretreated $49 cells in 
growth conditions (see section 2) with the agonist 
terbutaline (3 x 10 .6 M) for 16 h. After this in- 
cubation, cells had down-regulated the number of 
surface receptors per cell (CGP-12177 binding) to 
243 compared to an untreated control with 716 
receptors per cell. The pretreated cells were washed 
free of terbutaline and then incubated with 1 x 
10 -6 M IPR for 10 min at 37°C. Interestingly, the 
extent of internalization was found to be 58°70 with 
101 remaining surface receptors in comparison to 
63070 of control cells with 265 receptors remaining 
on the surface. Two other experiments using 
pretreatment with 1 × 10 -7 M and 5 X10 -7 M ter- 
butaline over 16 h yielded similar results, i.e. 57 
and 61070 internalized receptors, respectively. 
Receptor density per surface area does therefore 
not seem to be of importance for receptor inter- 
nalization in the absence of prior BAAM treat- 
ment. Alternative explanations for the observed 
effect of BAAM could be that either the chemical 
modification of receptors prevents the internaliza- 
tion of non-modified receptors or that the labelling 
of other sites, e.g. lipids, leads to the obstruction 
of internalization. 
Whatever the molecular basis for the reduction 
in the rate of internalization may be, we have 
shown that desensitization proceeds normally 
despite alterations in the rate of receptor inter- 
nalization. 
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